Pricing Log in Create free account

Gossamer Bio, Inc. (GOSS) vs Tenax Therapeutics, Inc. (TENX)

Gossamer Bio, Inc. and Tenax Therapeutics, Inc. are both Biotechnology companies. Gossamer Bio, Inc. and Tenax Therapeutics, Inc. are of similar size ($56.5M and $54.3M). Gossamer Bio, Inc. grew revenue faster over the last twelve months: 32.4% against −70.8%. Tenax Therapeutics, Inc. has the higher net margin (0.00% vs −235.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Tenax Therapeutics, Inc. leads on 9 and Gossamer Bio, Inc. on 6.

Valuation

Metric GOSS TENX Biotechnology median
P/E n/m n/m 8.50
P/S 0.65 201.11 9.71
P/B n/m 0.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.71 0.64
EV/Sales 3.99 (141.75) 9.21
Earnings yield (526.56%) (108.82%) (33.15%)
Free cash flow yield (469.68%) (66.58%) (25.50%)

Profitability

Metric GOSS TENX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (311.70%) 0.00% 0.00%
Net margin (235.00%) 0.00% 0.00%
Free cash flow margin (305.19%) 0.00% 0.00%
Return on equity 178.72% (59.80%) (56.36%)
Return on assets (78.81%) (57.02%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GOSS TENX Biotechnology median
Revenue growth (TTM) 32.43% (70.77%) 6.02%
EPS growth (last fiscal year) (200.00%) (16.52%) 30.26%
Revenue growth, 5-year CAGR — 0.79% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GOSS TENX Biotechnology median
Debt to equity (0.38) 0.00 0.00
Current ratio 0.53 15.07 4.72
Net debt to EBITDA (0.35) 1.73 0.96

Dividend

Metric GOSS TENX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GOSS TENX Biotechnology median
Market cap 54.32m 56.51m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack